6-chloro-4-(pyridin-3-yl)-1,4-dihydropyrazolo[4,3-b]indole

ID: ALA3798249

PubChem CID: 127048005

Max Phase: Preclinical

Molecular Formula: C14H9ClN4

Molecular Weight: 268.71

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Clc1ccc2c3[nH]ncc3n(-c3cccnc3)c2c1

Standard InChI:  InChI=1S/C14H9ClN4/c15-9-3-4-11-12(6-9)19(10-2-1-5-16-7-10)13-8-17-18-14(11)13/h1-8H,(H,17,18)

Standard InChI Key:  LMOBUEBHMONFLE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -4.1672    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6810    1.1807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2225    1.5280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1485   -1.3659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6669   -1.0186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2039    0.3704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4399   -1.9215    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7408   -1.0186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3010    0.3704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5048    1.2733    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7318    0.3704    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2688   -1.0186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4260   -3.4222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6444   -4.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5026   -5.7808    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1385   -6.4047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0838   -5.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9421   -4.0420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3578   -0.1497    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  9  1  0
  8  7  1  0
  7  5  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  7 13  1  0
  1 19  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3798249

    ---

Associated Targets(Human)

CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
METAP2 Tchem Methionine aminopeptidase 2 (1512 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 268.71Molecular Weight (Monoisotopic): 268.0516AlogP: 3.56#Rotatable Bonds: 1
Polar Surface Area: 46.50Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.77CX Basic pKa: 5.16CX LogP: 2.69CX LogD: 2.69
Aromatic Rings: 4Heavy Atoms: 19QED Weighted: 0.57Np Likeness Score: -1.60

References

1. McBride C, Cheruvallath Z, Komandla M, Tang M, Farrell P, Lawson JD, Vanderpool D, Wu Y, Dougan DR, Plonowski A, Holub C, Larson C..  (2016)  Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 2.,  26  (12): [PMID:27136719] [10.1016/j.bmcl.2016.04.072]

Source